New eye valve shows promise in early glaucoma trial
NCT ID NCT07480603
First seen Mar 27, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This early study tests a new drainage device for glaucoma that can adjust itself. The goal is to safely lower eye pressure in people whose glaucoma is not controlled by eye drops. Ten adults with advanced glaucoma will be followed after surgery to check for complications and pressure reduction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SwissVisio
Sali, Senegal
Conditions
Explore the condition pages connected to this study.